BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 19413906)

  • 1. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria.
    Picot S; Olliaro P; de Monbrison F; Bienvenu AL; Price RN; Ringwald P
    Malar J; 2009 May; 8():89. PubMed ID: 19413906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
    Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
    PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.
    Kinzer MH; Chand K; Basri H; Lederman ER; Susanti AI; Elyazar I; Taleo G; Rogers WO; Bangs MJ; Maguire JD
    Malar J; 2010 Apr; 9():89. PubMed ID: 20370920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of molecular markers for anti-malarial drug resistance after the introduction and scale-up of malaria control interventions in western Kenya.
    Shah M; Omosun Y; Lal A; Odero C; Gatei W; Otieno K; Gimnig JE; ter Kuile F; Hawley WA; Nahlen B; Kariuki S; Walker E; Slutsker L; Hamel M; Shi YP
    Malar J; 2015 Feb; 14():75. PubMed ID: 25889220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M; Djimde AA; Beavogui AH; Maiga H; Sagara I; Fofana B; Ouologuem D; Dama S; Kone A; Dembele D; Wele M; Dicko A; Doumbo OK
    Malar J; 2009 Feb; 8():34. PubMed ID: 19245687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.
    Boussaroque A; Fall B; Madamet M; Wade KA; Fall M; Nakoulima A; Fall KB; Dionne P; Benoit N; Diatta B; Diemé Y; Wade B; Pradines B
    Malar J; 2016 Jul; 15(1):347. PubMed ID: 27387549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular survey of Plasmodium falciparum resistance in south-eastern Iran.
    Jafari S; Le Bras J; Asmar M; Durand R
    Ann Trop Med Parasitol; 2003 Mar; 97(2):119-24. PubMed ID: 12803866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso.
    Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ
    Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
    Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
    Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
    Marfurt J; Smith TA; Hastings IM; Müller I; Sie A; Oa O; Baisor M; Reeder JC; Beck HP; Genton B
    Malar J; 2010 Jan; 9():8. PubMed ID: 20053293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pfcrt mutant haplotypes may not correspond with chloroquine resistance.
    Goswami D; Dhiman S; Rabha B; Kumar D; Baruah I; Sharma DK; Veer V
    J Infect Dev Ctries; 2014 Jun; 8(6):768-73. PubMed ID: 24916876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
    Marfurt J; Müller I; Sie A; Oa O; Reeder JC; Smith TA; Beck HP; Genton B
    Malar J; 2008 Apr; 7():61. PubMed ID: 18423045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.
    She D; Wang Z; Liang Q; Lu L; Huang Y; Zhang K; An D; Wu J
    BMC Infect Dis; 2020 Jul; 20(1):513. PubMed ID: 32677899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
    Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
    Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
    Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
    Ould Ahmedou Salem MS; Mint Lekweiry K; Bouchiba H; Pascual A; Pradines B; Ould Mohamed Salem Boukhary A; Briolant S; Basco LK; Bogreau H
    Malar J; 2017 Apr; 16(1):140. PubMed ID: 28381273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.